SGS Health Science has once again been recognized for its outstanding operations, receiving five 2023 CRO Leadership Awards in the categories of Capabilities, Compatibility, Expertise, Quality and Reliability.
This is the seventh consecutive year that SGS Health Science has won a CRO Leadership Award, and the second consecutive year that it has received an award in all categories for both Overall and Big Pharma. SGS Health Science also scored above average in two categories – Compatibility and Reliability – making it a 2023 CRO Leadership Award Champion.
The CRO Leadership Awards
The CRO Leadership Awards provide Clinical Leader and Life Science Leader's readers with accurate and reliable customer feedback to assist them in choosing a reputable CRO partner.
Qualified industry decision-makers that have partnered with health science CROs in the past 18 months provide detailed feedback via Industry Standard Research's (ISR) annual CRO Quality Benchmarking survey. This year, 46 contract research organizations were assessed on over 20 performance metrics. Ensuring that survey responses are based on actual involvement with CROs and clear experiential data, winners are judged by their customers as having exceeded their expectations.
The 2023 awards also recognized companies that scored above the weighted average in each of the core categories. SGS Health Science has been recognized as a top performer in the categories of Compatibility and Reliability.
"It is a true pleasure conducting our Phase 1 study together with SGS. Most strikingly, throughout the organization there is a culture of proactivity and ‘can do’ attitude as the team is always very responsive, and focused on solutions and opportunities instead of barriers. Congratulations to SGS for the well-deserved award!" said Anne Louise Kjølbye, PhD, MBA, Chief Development Officer, Cytoki Pharma.
Oliver Coppey, EVP Health and Nutrition, SGS, was thrilled to hear the news. "SGS Health Science continues to push the boundaries and deliver untold value to our clients," he said. "I'm proud that the 2023 CRO Leadership Awards has recognized our global teams' hard work, dedication and non-stop innovation."
Launching SGS PACE
These awards come in a pivotal year for SGS Health Science. It has recently launched SGS PACE, an integrated service connecting its bioanalysis, formulation and manufacturing, and clinical research capabilities–creating a streamlined pathway for molecules from preclinical, through formulation, and straight on to First In Human and Proof Of Concept studies conducted at our own Clinical Pharmacology Unit.
This exclusive service keeps clinical drug development efficient and on track, providing our clients with complete oversight at every stage of their drug pathways to ensure commercial success.
SGS Health Science
SGS's global network of analytical testing, formulation, clinical manufacturing and clinical research solutions offers a wide range of seamless integrated services and direct access to expertise. SGS experts are ready to support customers throughout the development of their drug products, helping ensure the delivery of safe, effective and compliant medicines to global markets.
For more information on SGS Health Science services such as SGS PACE, please contact:
Health Science - Head of Business Development and Support
t: +32 (0) 475 79 20 60
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 97,000 employees operate a network of 2,650 offices and laboratories, working together to enable a better, safer and more interconnected world.